The steady growth of the global infusion system market has been explored in a research report published by Market Research Future (MRFR) that estimates expansion for this market with 5% CAGR between 2017 and 2023. In terms of cash, the market is likely to rise to the US $ 9.7 bn during the forecast period.
The key factors that influence the growth of global infusion system market include high demand of the infusion systems in the military medical units, increased use of infusion pumps for the delivery of drugs and other fluids, rising prevalence of chronic and fatal diseases, and technological advancements from the leading market players. However, some factors that can obstruct the growth of this market include patient safety concerns, the risk of improper infusion leading to the severe consequences, and unmet medical needs in the low-income countries.
The global infusion system market has been segmented on the basis of application, end user, type, and lastly, region. As per the application, this market has been segmented into chemotherapy, diabetes, gastrointestinal disorders, pediatrics, and others. Based on the end user, the market has been segmented into ambulatory surgical centers, home care, and hospitals. By type, the market has been segmented into the ambulatory pump, syringe pump, and volumetric pump. According to the report, the volumetric pump holds the largest share of 37.1% of the market.
The regional segmentation of the global infusion system market segments the market into regional markets known as North America, Europe, Asia Pacific, and Middle East & Africa (MEA). Among all markets, North America is the largest market for infusion pumps. During the forecast period, it is expected to continue to hold this spot in the global infusion system market. By the end of 2023, North America market is expected to reach the US $ 3.49 bn. In North America, especially in the United States of America (USA), advanced technologies are continuously rising, creating a market for infusion pumps. The other important country-specific market in North America is Canada.
Europe is the second largest market, and during the forecast period, it is expected to reach nearly $3.11 bn. Western Europe is a bigger market than Eastern Europe due to advanced technology and medical facilities. Most countries with strong economies are also located in Western Europe which makes it the bigger market. In Western Europe, the most important country-specific markets are France, Germany, Italy, Spain, and the United Kingdom (UK), followed by the rest of Western Europe.
The Asia Pacific is a market that has lots of potential for the growth of the infusion system market because many continuously growing economies exist in this region. During the forecast period, it is expected to emerge as the fastest growing regional market with 5.4% CAGR. The recent developments in healthcare, improving economies, rising per capita income are leading to the growth of the market in this region. The maximum revenue of this market comes from Australia, China, India, Japan, and South Korea, followed by the rest of the Asia Pacific region.
The Middle East and Africa have less economic developments most countries in the MEA region have extremely low income. Therefore, the MEA region has the smallest market share. However, during the forecast period, the market in this region is likely to grow due to better infusion treatment in this region. The reasons for the low market in this region include lack of awareness, lack of education, lack of hygiene, lack of technological development, political instability, poor healthcare, and healthcare not considered a priority by most governments.
Key Players
The key players in the global infusion system market include 3M (USA), Asante (USA), Baxter International, Inc. (the USA), B. Braun Melsungen AG (Germany), Becton Dickinson & Company (USA), Biomedical Solutions (USA), CareFusion Corporation (USA), Flowonix Medical Inc (USA), Fresenius Kabi (Germany), Hospira, Inc (USA), ICU Medical, Inc. (USA), Johnson & Johnson (USA), Medtronic plc (Ireland), Micromed (UK), Mircel Medical Device (Greece), Moog Inc (USA), Pfizer, Inc. (USA), Q-Core (Israel), Roche Diagnostics (Switzerland), Smiths Medical (U.K.), Stryker (USA), and Terumo Medical Corporation (Japan).
Segmentation:
Infusion System market has been segmented on the basis of product type which comprises of IV disposable, Infusion pump, and others. IV disposable accounted for the largest market share of the total market in 2016. On the basis of application, market is segmented into Chemotherapy, diabetes, gastrointestinal diseases, pediatrics, and others. Chemotherapy segment accounted for the largest market share of the total market in 2016. On the basis of end user, market is segmented into hospitals, specialty oncology wards, homecare, and others. Hospitals dominated the global market with the largest market share in 2016
Regional Analysis:
Globally, North America is the largest market for Infusion System and is expected to commands the largest market share due to advanced technologies are continuously on rise in these countries. Europe accounts for the second largest market, where as Asia Pacific with lots of opportunity and continuously growing economies, is expected to be the fastest growing segment. This rapid growth is majorly due to recent developments in healthcare and improving economies and disposable income per individual. Middle East and Africa with less economic developments and extremely low income accounts for least market share in 2016 but is expected to grow with better infusion treatment in the countries

Sample report ttps://https://www.marketresearchfuture.com/sample_request/1210
Market senariyo –
The Global market for infusion system is growing at a steady pace. The various factors that influence the growth of the market are increased use of infusion pumps for the delivery of drugs and other fluids, rising prevalence of chronic and fatal diseases, high demand of the infusion systems in the military medical units, technological advancements from the leading market players. Furthermore the factors such as patient safety concerns and improper infusion leading to the severe consequences, unmet medical needs in the low income countries are hampering the growth of the market. Globally the market for infusion system is expected to grow at the rate of about 4.9% from 2017 to 2025





About Markets research future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.


Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +16468459312
Email: [email protected]